Now livetag icon
2026 State of Ecommerce: Own the AI Shopper Journey.Download Reportbanner icon
Neopharm

August 2026

Neopharm Market Share Analysis for August 2026

Discover Choco Bears Resista Kids® - delicious power for immunity.
Year Founded1996
Employees51 - 200
Annual Revenue$2M - $5M
neopharm.bg
Neopharm
Neopharm (including company regionals)
  • neopharm.bg
    neopharm.bg
See more website traffic and engagement information

Neopharm Revenue up to August 2026 is 2M - 5M

revenue generated by Neopharm top domains

Neopharm top domains revenue over 3 years

Revenue for Neopharm top domains


Total visits to Neopharm's top domains

Understand Neopharm market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Neopharm's top domains

Analyze Neopharm engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Neopharm's top domains

See how Neopharm keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Neopharm top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Neopharm

These are the website technologies, by industry, used by Neopharm top domains

Advertising (5)

Google Adsense

Google Adsense

Widget (3)

reCAPTCHA

reCAPTCHA

Audio Video Media (2)

YouTube

YouTube

Conversion & Analytics (2)

Google Analytics

Google Analytics

More Technologies

8

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.